ALK-Abelló A/S (OTCMKTS:AKBLF) Short Interest Up 64.3% in August

ALK-Abelló A/S (OTCMKTS:AKBLF) was the recipient of a large growth in short interest during the month of August. As of August 31st, there was short interest totaling 133,283 shares, a growth of 64.3% from the August 15th total of 81,130 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is currently ? days.

ALK-Abelló A/S Price Performance

AKBLF stock opened at $32.47 on Friday. ALK-Abelló A/S has a 12 month low of $28.95 and a 12 month high of $40.65. The company has a 50-day moving average price of $37.12 and a 200 day moving average price of $36.21.

ALK-Abelló A/S Company Profile

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food.